Stereochemistry | RACEMIC |
Molecular Formula | C16H27N7O5.OTc |
Molecular Weight | 512.3351 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 2 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
O=[99Tc+3].C\C(=N/[O-])C(C)(C)NCC(CN1C=CN=C1[N+]([O-])=O)ONC(C)(C)C(\C)=N\[O-]
InChI
InChIKey=YCWYKEIFNMLCQH-KQKUEPDFSA-L
InChI=1S/C16H29N7O5.O.Tc/c1-11(19-24)15(3,4)18-9-13(28-21-16(5,6)12(2)20-25)10-22-8-7-17-14(22)23(26)27;;/h7-8,13,18,21,24-25H,9-10H2,1-6H3;;/q;;+3/p-2/b19-11+,20-12+;;/i;;1+1
Molecular Formula | C16H27N7O5 |
Molecular Weight | 397.4295 |
Charge | -2 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 2 |
Optical Activity | ( + / - ) |
Molecular Formula | OTc |
Molecular Weight | 114.9057 |
Charge | 3 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.